"Peacemaker" immune cells could help treat diseases ranging from type 1 diabetes to neurodegeneration by restoring immune ...

According to estimates from the World Health Organization (WHO), there will be 18.1 million new cases and 9.6 million cancer deaths worldwide in 2018. Cancer is a serious disease that affects people ...

In the weeks following a stroke, regulatory T cells stream into the brain. What exactly do they do there? Scientists led by Akihiko Yoshimura, Keio University School of Medicine, Tokyo, report in the ...

Lower regulatory T cells (Tregs) at diagnosis in patients with multiple myeloma were linked to early relapse and may indicate functional high-risk status (FHR). FHR patients experience aggressive ...

Regulatory T cells, Tregs (pronounced "T" "regs") for short, represent a divisive type of immune cell that can elicit beneficial but also harmful effects. As their name suggests, Tregs regulate the ...

Expression of co-inhibitory receptors or “checkpoint” molecules, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated expression of ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of infection, these so-called Tregs restrain the immune system to ensure it ...

Tolerance is the holy grail in calming autoimmune disease, a truce in the immune system’s faulty battle against the body’s own fabric. In type 1 diabetes, immune fighters attack beta cells in the ...

DelveInsight's Regulatory T-cells (Tregs) Market Insights report includes a comprehensive understanding of emerging Tregs-based therapies, market share of individual therapies, and forecasted ...

Tregs are ideal candidates for tolerance induction in the clinical context of solid organ and alloHSCT and may represent an ideal tool for an adoptive cellular therapy for inducing tolerance, ...